My Cellular Orthopedic/Regenerative Medicine practice is evidence-based. In short, we integrate patient care with research. Our outcomes and patient satisfaction data over the last two years clearly show that the highly concentrated injectate of A2M and concentrated Growth Factor Proteins contained in our proprietary PRP solution is so more successful than the Hyaluronic acid injections (the gel/cushion) that we have discontinued use of the non-biologic option. Blood plasma is produced by the human body and contains a high level of proteins and growth factors that have healing properties helping the body repair itself while blocking pain from inflammation secondary to osteoarthritis. Proteins are concentrated from the patient’s own blood and injected into damaged joints of the body to diminish or eliminate symptoms, enhance function and promote regeneration.
As an example of the evidence, an athletic, active, physical therapist presented a year ago with a painful knee developed during the course of training for a marathon. The patient was forced to give up running. After a course of non-steroidal, anti-inflammatory medication, imaging was compatible with structural changes in the meniscus and articular cartilage of the knee. A cortisone injection rendered short-term relief. The hyaluronic acid injection that followed for several weeks was of no value. An arthroscopic evaluation and debridement (shaving) did not diminish symptoms or allow for a return to an athletic profile. Four months ago, the patient underwent a bone marrow concentrate intervention into the problematic knee. Four weeks later, a proprietary PRP injection was administered to the same knee as part of my treatment protocol. A hike into the Grand Canyon with family had been planned one year ago. This past Monday, my patient returned from the trek complaining of “sore calf muscles”, but, had enjoyed painless and unlimited participation in a grueling five-day event.
The ethos of my Cellular Orthopedic/ Regenerative Medicine practice is to stop the progression of painful conditions such as osteoarthritis with a needle and not a knife. The above vignette is one approach. Anticipated by midyear is a second Trial in which your adipose stored stem cells are made available for injection into the arthritic joint offering yet another treatment alternative. You may visit my website at www.sheinkopmd.com to learn more. For an in-office consultation, call (312) 475-1893. Follow the announcement of the Personalized Stem Cell Clinical Trial at www.PersonalizedStemCells.com